{"name":"Nandrolone","slug":"nandrolone","kind":"substance","abbreviations":[],"systematic":null,"aliases":["19-Nortestosterone","Nortestosterone","Norandrostenolone","19-Norandrostenolone","Menidrabol","Nortestonate","Nandrolon","Oestrenolon","Norandrostenolon","17β-Hydroxy-4-estren-3-one"],"brands":[],"scraped":true,"has_structure":true,"cid":9904,"classes":[{"name":"androgen","href":"/class/androgen"},{"name":"steroid","href":"/class/steroid"}],"families":[{"name":"steroid","href":"/substituted/steroid"}],"physical":[{"label":"Molecular mass","value":"274.40 g/mol","copyable":false},{"label":"Appearance","value":"Dimorphic crystals","copyable":false},{"label":"Melting point","value":"112 and 124 °C","copyable":false},{"label":"Solubility","value":"Soluble in ether, chloroform, and alcohol","copyable":false},{"label":"Predicted LogP","value":"2.6","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>18</sub>H<sub>26</sub>O<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"(8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one","copyable":true},{"label":"SMILES","value":"C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34","copyable":true},{"label":"InChI","value":"InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1","copyable":true},{"label":"InChIKey","value":"NPAGDVCDWIYMMC-IZPLOLCNSA-N","copyable":true},{"label":"CAS number","value":"434-22-0","copyable":true},{"label":"UNII","value":"6PG9VR430D","copyable":true},{"label":"PubChem CID","value":"9904","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"• Nandrolone: &lt;4.3 hours, • Nandrolone decanoate (Intramuscular injection): 6–12 days, • Nandrolone phenylpropionate: 2.7 days<a href=\"#cite_note-3\"><sup>[3]</sup></a><a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false},{"label":"Duration of action","value":"• Nandrolone decanoate (Intramuscular injection): 2–3 weeks, • Nandrolone phenylpropionate (Intramuscular injection): 5–7 days<a href=\"#cite_note-5\"><sup>[5]</sup></a>","copyable":false},{"label":"Metabolism","value":"Liver (reduction)<a href=\"#cite_note-6\"><sup>[6]</sup></a>","copyable":false},{"label":"Excretion","value":"Urine","copyable":false},{"label":"Routes of administration","value":"• Intramuscular injection (esters), • Subcutaneous injection (esters), • Eye drops (nandrolone sulfate)","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"A","description":"Alimentary tract and metabolism"},{"code":"A14","description":"Anabolic agents for systemic use"},{"code":"A14A","description":"Anabolic steroids"},{"code":"A14AB","description":"Estren derivatives"},{"code":"A14AB01","description":"Nandrolone"},{"code":"S","description":"Sensory organs"},{"code":"S01","description":"Ophthalmologicals"},{"code":"S01X","description":"Other ophthalmologicals"},{"code":"S01XA","description":"Other ophthalmologicals"},{"code":"S01XA11","description":"Nandrolone"}],"mesh":[{"name":"Androgens","id":"M0001106"},{"name":"Anabolic Agents","id":"M0450262"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Functionally overloading rat soleus muscle by synergist ablation induces a rapid increase in mass. Muscle remodeling during the first week of overload is critical for the overload-induced growth. Anabolic steroid modulation of this overload-induced remodeling response is not well understood. The purpose of this study was to determine whether pretreatment with nandrolone decanoate, a clinically administered anabolic steroid, alters muscle morphology and gene expression related to muscle growth during the initiation of functional overload in the rat soleus muscle. Adult (5 mo) male Fisher 344 x Brown Norway rats were randomly assigned to control (Sham), 3-day functional overload (OV), nandrolone decanoate administration (ND), or 3-day functional overload with nandrolone decanoate administration (OV+ND) treatment groups. Morphologically, OV increased the percentage of small (361%) and large (150%) fibers and expanded the ECM 50%. ND administration decreased the 3-day OV induction of small fibers 51% and nuclei associated with the ECM 20%. ND administration also attenuated the induction of cell cycle regulator p21 (64%) and myogenin (37%) mRNAs after 3 days of overload. These data demonstrate that nandrolone decanoate pretreatment can alter morphological and cell cycle regulator expression related to muscle growth at the onset of functional overload.","side_effects":{"drug_id":9904,"drug_name":"nandrolone","url":"https://sideeffects.embl.de/drugs/9904/pt","atc_codes":["A14AB01","S01XA11"],"side_effects":[{"name":"Alopecia","cui":"C0002170"},{"name":"Libido decreased","cui":"C0011124"},{"name":"Disturbance in sexual arousal","cui":"C0855242"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Oedema","cui":"C0013604"},{"name":"Epididymitis","cui":"C0014534"},{"name":"Gynaecomastia","cui":"C0018418"},{"name":"Haemorrhage","cui":"C0019080"},{"name":"Haemoglobin","cui":"C0518015"},{"name":"Hirsutism","cui":"C0019572"},{"name":"Irritability","cui":"C0022107"},{"name":"Nausea","cui":"C0027497"},{"name":"Neoplasm","cui":"C0027651"},{"name":"Azoospermia","cui":"C0004509"},{"name":"Peliosis hepatis","cui":"C0030781"},{"name":"Priapism","cui":"C0033117"},{"name":"Vomiting","cui":"C0042963"},{"name":"Glucose tolerance decreased","cui":"C0151671"},{"name":"Testicular atrophy","cui":"C0156312"},{"name":"Enlarged clitoris","cui":"C0156394"},{"name":"Menstruation irregular","cui":"C0156404"},{"name":"Erectile dysfunction","cui":"C0242350"},{"name":"Drug interaction","cui":"C0687133"},{"name":"Acne","cui":"C0702166"},{"name":"Insomnia","cui":"C0917801"}],"indications":[{"name":"Anaemia","cui":"C0002871"},{"name":"Renal impairment","cui":"C1565489"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"C5","act":null,"refs":[7]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class C","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule III","act":"Controlled Substances Act","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Nandrolone"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/9904"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q421709"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB13169"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL757"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A7466"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=434-22-0"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0002725"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07254"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID7023350"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Nandrolone"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/6PG9VR430D"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/9904/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 9904, Nandrolone. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/9904>https://pubchem.ncbi.nlm.nih.gov/compound/9904</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Nandrolone. UNII: 6PG9VR430D. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6PG9VR430D>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6PG9VR430D</a>","Deca-Durabolin. Schering-Plough. <a href='http://www.medsafe.govt.nz/profs/Datasheet/d/Decadurabolininj.pdf'>http://www.medsafe.govt.nz/profs/Datasheet/d/Decadurabolininj.pdf</a>","Minto CF, Howe C, Wishart S, Conway AJ, Handelsman DJ. Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. The Journal of Pharmacology and Experimental Therapeutics. April 1997; 281(1):93–102. PMID 9103484. <a href='https://doi.org/10.1016/S0022-3565(24)36598-X'>https://doi.org/10.1016/S0022-3565(24)36598-X</a>","Deca-Durabolin. Merck Sharp &amp; Dohme (Australia). <a href='https://gp2u.com.au/static/pdf/D/DECA-DURABOLIN-PI.pdf'>https://gp2u.com.au/static/pdf/D/DECA-DURABOLIN-PI.pdf</a>","Thomas JA. Drugs, Athletes, and Physical Performance. Springer Science &amp; Business Media. 6 December 2012. <a href='https://books.google.com/books?id=9u0pBgAAQBAJ&amp;pg=PA27'>https://books.google.com/books?id=9u0pBgAAQBAJ&amp;pg=PA27</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 17:12:28","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 17:12:24","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 17:12:24","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 17:12:24","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 17:12:24","note":"hmdb.ca refused automated access to HMDB0002725"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 17:12:26","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 17:12:24","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 17:12:24","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 17:12:24","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 17:12:24","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 17:12:24","note":null}],"description":"Nandrolone is a androgen, steroid substance."}